| Elafibranor, an agonist of the peroxisome proliferator− activated receptor− α and− δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening V Ratziu, SA Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, ... Gastroenterology 150 (5), 1147-1159. e5, 2016 | 1131 | 2016 |
| Epidemiology and natural history of nonalcoholic fatty liver disease SK Satapathy, AJ Sanyal Seminars in liver disease 35 (03), 221-235, 2015 | 438 | 2015 |
| Beneficial effects of tumor necrosis factor-α inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis SK Satapathy, S Garg, R Chauhan, P Sakhuja, V Malhotra, BC Sharma, ... Official journal of the American College of Gastroenterology| ACG 99 (10 …, 2004 | 281 | 2004 |
| A randomized controlled trial of lamivudine to treat acute hepatitis B M Kumar, S Satapathy, R Monga, K Das, S Hissar, C Pande, BC Sharma, ... Hepatology 45 (1), 97-101, 2007 | 271 | 2007 |
| A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis SA Harrison, Z Goodman, A Jabbar, R Vemulapalli, ZH Younes, B Freilich, ... Journal of hepatology 72 (5), 816-827, 2020 | 229 | 2020 |
| Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non‐alcoholic steatohepatitis SK Satapathy, P Sakhuja, V Malhotra, BC Sharma, SK Sarin Journal of gastroenterology and hepatology 22 (5), 634-638, 2007 | 229 | 2007 |
| Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management G Cholankeril, R Patel, S Khurana, SK Satapathy World journal of hepatology 9 (11), 533, 2017 | 218 | 2017 |
| Impact of COVID‐19 pandemic on liver transplantation and alcohol‐associated liver disease in the USA G Cholankeril, K Goli, A Rana, R Hernaez, A Podboy, P Jalal, BL Da, ... Hepatology 74 (6), 3316-3329, 2021 | 186 | 2021 |
| Direct-acting antiviral therapy for hepatitis C virus infection is associated with increased survival in patients with a history of hepatocellular carcinoma AG Singal, NE Rich, N Mehta, AD Branch, A Pillai, M Hoteit, M Volk, ... Gastroenterology 157 (5), 1253-1263. e2, 2019 | 168 | 2019 |
| Prevalence, risk factors, and outcomes of hospitalized patients with coronavirus disease 2019 presenting as acute pancreatitis S Inamdar, PC Benias, Y Liu, DV Sejpal, SK Satapathy, AJ Trindade, ... Gastroenterology 159 (6), 2226, 2020 | 163 | 2020 |
| Direct-acting antiviral therapy not associated with recurrence of hepatocellular carcinoma in a multicenter North American cohort study AG Singal, NE Rich, N Mehta, A Branch, A Pillai, M Hoteit, M Volk, ... Gastroenterology 156 (6), 1683-1692. e1, 2019 | 161 | 2019 |
| Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension G Garcia-Tsao, J Bosch, Z Kayali, SA Harrison, MF Abdelmalek, E Lawitz, ... Journal of hepatology 72 (5), 885-895, 2020 | 143 | 2020 |
| Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice SK Satapathy, M Ochani, M Dancho, LQK Hudson, M Rosas-Ballina, ... Molecular medicine 17, 599-606, 2011 | 127 | 2011 |
| Drug-induced fatty liver disease: An overview of pathogenesis and management SK Satapathy, V Kuwajima, J Nadelson, O Atiq, AJ Sanyal Annals of hepatology 14 (6), 789-806, 2015 | 126 | 2015 |
| Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis AJ Kovalic, SK Satapathy, PJ Thuluvath Hepatology international 14 (5), 612-620, 2020 | 124 | 2020 |
| Prevalence and profile of nonalcoholic fatty liver disease in lean adults: systematic review and meta‐analysis S Young, R Tariq, J Provenza, SK Satapathy, K Faisal, A Choudhry, ... Hepatology communications 4 (7), 953-972, 2020 | 122 | 2020 |
| Transplantation of kidneys from hepatitis C–infected donors to hepatitis C–negative recipients: Single center experience MZ Molnar, S Nair, O Cseprekal, M Yazawa, M Talwar, V Balaraman, ... American Journal of Transplantation 19 (11), 3046-3057, 2019 | 117 | 2019 |
| Comparative survival analysis of immunomodulatory therapy for coronavirus disease 2019 cytokine storm S Narain, DG Stefanov, AS Chau, AG Weber, G Marder, B Kaplan, ... Chest 159 (3), 933-948, 2021 | 108 | 2021 |
| Beneficial effects of statins on the rates of hepatic fibrosis, hepatic decompensation, and mortality in chronic liver disease: a systematic review and meta-analysis S Kamal, MA Khan, A Seth, G Cholankeril, D Gupta, U Singh, F Kamal, ... Official journal of the American College of Gastroenterology| ACG 112 (10 …, 2017 | 106 | 2017 |
| Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial FM Consolim-Colombo, CT Sangaleti, FO Costa, TL Morais, HF Lopes, ... JCI insight 2 (14), 2017 | 88 | 2017 |
